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Exploration of sensory and spinal neurons
expressing gastrin-releasing peptide
in itch and pain related behaviors
1234567890():,;

Devin M. Barry 1,2, Xue-Ting Liu 1,2,3, Benlong Liu1,2, Xian-Yu Liu1,2, Fang Gao 1,2, Xiansi Zeng 1,2,6,
Juan Liu 1,2, Qianyi Yang1,2, Steven Wilhelm 1,2, Jun Yin 1,2, Ailin Tao 1,3 & Zhou-Feng Chen1,2,4,5 ✉

Gastrin-releasing peptide (GRP) functions as a neurotransmitter for non-histaminergic itch,
but its site of action (sensory neurons vs spinal cord) remains controversial. To determine the
role of GRP in sensory neurons, we generated a ﬂoxed Grp mouse line. We found that
conditional knockout of Grp in sensory neurons results in attenuated non-histaminergic itch,
without impairing histamine-induced itch. Using a Grp-Cre knock-in mouse line, we show that
the upper epidermis of the skin is exclusively innervated by GRP ﬁbers, whose activation via
optogeneics and chemogenetics in the skin evokes itch- but not pain-related scratching or
wiping behaviors. In contrast, intersectional genetic ablation of spinal Grp neurons does not
affect itch nor pain transmission, demonstrating that spinal Grp neurons are dispensable for
itch transmission. These data indicate that GRP is a neuropeptide in sensory neurons for nonhistaminergic itch, and GRP sensory neurons are dedicated to itch transmission.
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odality-speciﬁc information is transmitted and processed through the superﬁcial dorsal horn of the spinal
cord. Primary afferents of sensory neurons release fast
neurotransmitters (e.g. glutamate) and neuropeptides to activate
postsynaptic receptors in the spinal cord dorsal horn to transmit
itch and pain information1–4. Previous evidence suggested that
gastrin-releasing peptide (GRP) is a principal neuropeptide for
transmitting non-histaminergic itch from primary afferents to
GRP-receptor (GRPR) neurons in the dorsal horn1,5–9. The
potential evolutionary role for GRP was supported by the ﬁnding
that GRP in the suprachiasmatic nucleus of hypothalamus is
crucial for contagious itch behavior10 and by its conserved
expression in the dorsal root ganglion (DRG) neurons between
rodents and primates8,11–13, and more recently in dogs14.
In contrast, neuromedin B (NMB), the second mammalian
bombesin-related neuropeptide15, relays histamine-evoked itch
from DRGs to the dorsal horn interneurons expressing NMB
receptor (NMBR)6,16. However, there are considerable disagreements whether Grp is expressed in DRGs7,17–21, due to its relatively low copy number of mRNA. Although the presence of Grp
mRNA in DRGs has been well described, the direct evidence for
the role of GRP is still lacking. Addressing this question necessitates the generation of ﬂoxed Grp mice for DRG-speciﬁc
knockout (KO). On the other hand, attracted by abundant Grp
mRNA expression in the spinal cord19,22, spinal Grp neurons
have been postulated to act either as a dedicated neural station
that sends itch information to GRPR neurons via release of
GRP17,23,24, or a “leaky gate” for itch and pain25. These studies,
however, employed GENSAT’s BAC transgenic Grp-Cre/eGFP
mouse lines which capture only approximately 25% of endogenous Grp expression in the spinal cord18,24,26, indicating a lack
of utility of BAC Grp mouse lines for functional interrogation of
spinal Grp neurons in itch and pain. A critical appraisal of the
function of Grp neurons in the spinal cord using intersectional
genetic ablation combined with the gold standard itch behavioral
assay entails a generation of a high-ﬁdelity Grp-Cre mouse line
using knock-in approach.
In this study, we generated and validated a long-sought knockin allele in which Cre recombinase (Cre) is driven under the
control of the endogenous Grp promoter (GrpCre-KI) and a ﬂoxed
Grp allele for conditional deletion of Grp in DRGs. Using these
mouse toolkits, we investigated the role of Grp in DRGs, GRP
primary afferents and spinal Grp neurons in itch and pain.
Results
GrpCre-KI expression in sensory neurons and skin ﬁbers. To
investigate the role of Grp sensory neurons in itch, a targeting
construct was generated with an eGFP-Cre recombinase cassette
and knocked-in at exon 1 start codon of Grp (GrpCre-KI) in mice
(Fig. 1a, b). eGFP-positive neurons in DRG were detected following immunohistochemistry (IHC) with a GFP antibody, but
epiﬂuorescent eGFP signals were not observed (Fig. 1c, d).
Moreover, the GFP antibody did not detect any signals in GrpWT
tissues (Supplementary Fig. 1a). To validate speciﬁc expression of
Grp in DRG neurons, we employed RNAScope™ in situ hybridization (ISH) methods27 and found that Grp was detected in a
subset of wild-type (WT) DRG neurons (~7%) but not in Grp KO
tissues (Supplementary Fig. 1b, c). This result is consistent with
Grp mRNA (~7%) detected by conventional digoxygenin (DIG)
(Supplementary Fig. 1d) as well as previous studies7,19. To verify
the activity of Cre recombinase in adult DRGs, Cre-dependent
eYFP virus (AAV5-EF1α-DIO-eYFP) was injected into the DRGs
of adult GrpCre-KI mice. Three weeks after virus injections, eYFP
was expressed in DRG neurons, which also expressed GRP
(Fig. 1e–g). These results indicate that Cre recaptitulates the
2

expression of GRP in DRG. Previously we found that the signal of
GRP immunostaining was signiﬁcantly reduced in the SCN after
mice watched scratching video, suggesting that GRP was released
to activate GRPR neurons to mediate contagious itch behavior10.
We speculated that if GRP functions as an itch peptide in DRGs,
it should also be released into the spinal cord in response to
intradermal injection (i.d.) of a pruritogen, resulting in reduced
immunostaining of GRP ﬁbers. To test this, we performed GRP
antibody staining in the cervical spinal sections following i.d.
injections of chloroquine (CQ), a non-histaminergic pruritogen
that is mediated by GRP-GRPR signaling5. The GRP immunostaining signals on the ipsilateral side of CQ injection were signiﬁcantly reduced compared to the contralateral side (p = 0.017)
(Fig. 1h). In contrast, substance P (SP) IHC signaling were similar
between two sides of the cervical spinal cord following CQ
injections (p > 0.99) (Fig. 1i). These results suggest that GRP in
the primary afferents was released upon itch stimulation.
To characterize innervation of Grp sensory neurons in the skin,
GrpCre-KI mice were crossed with the tdTomato ﬂox-stop reporter
line (Ai14)28 to generate mice with tdTomato expression in Grp+
neurons (GrptdTom)(Fig. 2a). To validate tdTomato expression,
we performed IHC of eGFP with tdTomato epiﬂuorescent signals
in GrptdTom DRGs. tdTomato was expressed in nearly all DRG
neurons that expressed eGFP in GrptdTom mice (98/99 tdTom/
eGFP and 98/102 eGFP/tdTom neurons) (Fig. 2b, c). IHC of GRP
in DRG of GrptdTom mice conﬁrmed that tdTomato epiﬂuorescent signals are colocolalized with GRP (Fig. 2d–f). We also
validated the GrpCre-KI expression in the spinal cord by Grp ISH
in GrptdTom spinal sections and found that 89% of tdTomato+
neurons expressed Grp mRNA, and, importantly, 93% of Grp
mRNA+ neurons expressed tdTomato (Supplementary Fig. 2c–e).
Of note, GRP antibody labeled neuronal terminals in the
superﬁcial dorsal horn but not cell bodies (Fig. 2g–i). Importantly, GRP IHC staining in the spinal cord exhibits a
characteristic feature that resembles those neuropeptides originated in DRGs such as CGRP: the most intense staining is present
in the most superﬁcial layer, with gradual reduction onto lamina
II. Such a pattern does not ﬁt with the notion that GRP is released
from endogenous spinal Grp neurons, which, if they function
only through GRPR neurons directly, should exhibit laminae I–II
restricted homogenous IHC pattern. Intriguingly, while GrptdTom
cells were present in DRGs and innervate the skin broadly (see
below), we did not detect central terminals marked by tdTomato
in the spinal cord (Fig. 2g). The lack of tdTomato-labled central
terminals has also been shown in other Cre lines, such as Tac1CretdTomato mouse line29. The reason for this discrepancy is
currently unknown. Nevertheless, tdTomato expression was not
detected in the DRG and skin of GrpWT;Ai14 mice (Supplementary Fig. 2a, b). The results indicate that tdTomato expression
faithfully recapitulates Grp expression and can be used as a
surrogate for Grp ﬁbers.
To characterize the innervation organization of GRP ﬁbers in
the skin, we examined a wide array of tissues and found that they
received innervation from GrptdTom ﬁbers with a focus on the
epidermis and cutaneous structures (Supplementary Table 1).
GrptdTom was observed in nerve ﬁbers of hairy nape skin, with
apparent co-expression in some ﬁbers expressing calcitonin generelated peptide (CGRP), a peptidergic marker of nociceptive
neurons (Fig. 2j, arrows)30. Some GrptdTom ﬁbers that were
CGRP-negative wrapped around the upper epidermal regions of
hair follicles as apparent circular or penetrating follicle neck
endings (Fig. 2j, asterisk). GrptdTom ﬁbers showed apparent
intertwining with CGRP ﬁbers or with some ﬁbers showing coexpression. Next, we examined the thicker glabrous skin of the
paw to better visualize the termination zones of GrptdTom ﬁbers.
Many GrptdTom ﬁbers projected from the dermal/epidermal
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Fig. 1 Validated expression of Grp and Cre in GrpCre-KI sensory neurons. a Schematic of targeting strategy to knock in eGFP-Cre cassette in Grp allele to
generate GrpCre-KI mice. b Gel electrophoresis of genotyping PCR from Grp Cre/wt, wt/wt, and Cre/Cre samples. c eGFP IHC from DRG section of an adult
GrpCre-KI mouse. d Image of eGFP epiﬂuorescent signal (no GFP antibody) in GrpCre-KI DRG. e–g GRP IHC (e) and eYFP ﬂuorescent image (f) from DRG
section of an adult GrpCre-KI mouse that received AAV5- EF1α-DIO-eYFP injection into the DRG for 3 weeks. Scale bar, 20 μm. h and i IHC of GRP (h) and
SP (i) in cervical spinal sections from WT mice following i.d. injections of CQ (200 μg). Scale bar, 100 μm. Data are presented as mean ± s.e.m., n = 3 mice
and 9 sections. Source data are provided as a Source Data ﬁle.

boundary, mostly straight up through the stratum basilis and
stratum spinosum, but then meandered and wrapped around
keratinocytes in apparent ‘S’ or ‘Z’ pattern free endings (arrows)
or as bush/cluster endings (arrowhead) within the stratum
granulosum and terminated ~5 μm from the stratum corneum
(Fig. 2k, red). In contrast, most of the CGRP ﬁbers along with a
few GrptdTom ﬁbers (asterisk) were straight with less complexity
and terminated mostly in the stratum spinosum (Fig. 2k, green).
GrptdTom was not co-expressed with myelinated ﬁbers using an
antibody against neuroﬁlament heavy (NF-H)(Supplementary
Fig. 2f–h)31,32, and no GrptdTom ﬁbers were observed in any

sensory structures that are typically innervated by myelinated
ﬁbers including Merkel cell-complexes, Meissner corpuscles,
vibrissa follicle-sinus complexes, or sebaceous glands (Supplementary Table 1). GrptdTom ﬁbers were also absent from the
heart, esophagus, intestine, kidney, liver, lung, and testis
(Supplementary Table 1). GrptdTom ﬁbers were rarely observed
in the epithelial layers of the tongue, cornea, and bladder
(Supplementary Fig. 2i–k). GrptdTom ﬁbers were also barely
present in skeletal muscle within coursing nerve bundles with
CGRP ﬁbers but did not innervate muscle ﬁbers or the
neuromuscular junction (Supplementary Fig. 2l, m).
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Grp is expressed in a subset of peptidergic sensory neurons.
DRG neurons can be extensively divided into different subsets
based upon expression proﬁles of various molecular markers as
well as their size distributions33,34. We analyzed GrptdTom
expression in DRG using several classic neuronal markers.
GrptdTom sensory neurons co-expressed CGRP (arrowheads)
(71.1%, 54/76) or the non-peptidergic Isolectin B4 (IB4)-binding
(arrowheads) (26.0%, 33/127) (Fig. 3a–d)35,36. GrptdTom neurons
also co-expressed transient receptor potential cation channel
subfamily V member 1 (TRPV1)37,38 (arrowheads) (74.8%, 86/
115) (Fig. 3e, f). Consistent with our ﬁnding that GrptdTom was
not observed in myelinated ﬁbers of skin sensory structures,
GrptdTom DRG neurons rarely expressed NF-H (2.4%, 5/204)
(Supplementary Fig. 3a, b). Next we performed ISH to determine
expression of Grp with an itch-speciﬁc receptor Mrgpra339, or
with histamine receptor 1, Hrh140. Mrgpra3 was co-expressed in
most Grp neurons (65.2%, 47/72) (Fig. 3e, f), and nearly half of
Mrgpra3 neurons co-expressed Grp (41.2%, 47/114). Hrh1 was
co-expressed in a majority of Grp neurons (56.2% 36/64 neurons)
(Fig. 3g, h), whereas a small portion of Hrh1 neurons coexpressed Grp (20.8%, 36/173). Lastly, we further characterized
GrptdTom DRG neurons by measuring the area (μm2) of perikarya
as well as for CGRP and IB4 neurons (Supplementary Fig. 3c).
The areas of GrptdTom neuron perikarya were typically less than
that of CGRP and IB4 neurons (GrptdTom 292 ± 13 μm2 vs CGRP
369 ± 16 μm2 vs IB4 364 ± 9 μm2). Overall, the size proﬁles
indicate that GrptdTom neurons are mostly smaller sized neurons
4

and show similar distributions to CGRP or IB4 populations, albeit
shifted to a slightly smaller area proﬁle than CGRP or IB4.
Grp sensory neurons are activated by pruritogens. To investigate the responsiveness of Grp sensory neurons to pruritogens,
we performed Ca2+ imaging of cultured DRG neurons from
GrptdTom mice. tdTomato+ neurons were observed in culture
and loaded with the ratiometric indicator fura2-AM for live-cell
imaging of intracellular Ca2+ levels as described41(Fig. 4a, b).
Chloroquine (CQ) and histamine (Hist), two archetypal pruritogens for non-histaminergic and histaminergic itch, respectively, were applied separately, followed by capsaicin (Cap),
a potent agonist of TRPV142 which can also signal itch
via Mrpgra3 neurons43, and potassium chloride (KCl) as a
positive control response (Fig. 4c, d). We found that ~74% of
GrptdTom neurons responded to CQ (72/97) and ~52% of CQresponsive neurons expressed GrptdTom (72/138) (Fig. 4e).
~52% GrptdTom neurons responded to Hist (51/97) and ~33% of
Hist-responsive neurons expressed GrptdTom (51/156) (Fig. 4e).
Approximately 41% of GrptdTom neurons were responsive to
both CQ and Hist (40/97) (Fig. 4e). Most GrptdTom neurons also
responded to Cap (~81%, 79/97) (Fig. 4e). As with DRG tissues,
cultured GrptdTom DRG neurons co-expressed CGRP, IB4 and
TRPV1 but almost no co-expression with NF-H (Supplementary Fig. 4a, b). Taken together, the data suggested that the
vast majority of GrptdTom sensory neurons are activated by
pruritogens.
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Fig. 3 Grp expression is enriched in a subset of sensory neurons with both peptidergic and non-peptidergic markers. a, c, e IHC image of tdTomato with
CGRP (a), IB4 (c), and TRPV1 (e) in GrptdTom DRG. Arrowheads indicate double stained neurons. Scale bar, 50 μm. b, d, f Venn Diagram of DRG neurons
with tdTomato/CGRP expression, tdTomato/IB4-binding, and tdTomato/TRPV1 expression from GrptdTom mice. g ISH of Grp and Mrgpra3 in WT DRG.
Scale bar, 20 μm. h Diagram of DRG neurons with Grp and Mrgpra3 expression. i ISH of Grp and Hrh1 in WT DRG. j Diagram of DRG neurons with Grp and
Hrh1 expression. n = 3 mice and 9 sections.

Opto-activation of Grp ﬁbers induces itch-speciﬁc behavior.
Since Grp is also expressed in the spinal cord, it is technically
difﬁcult to inactivate Grp neurons exclusively in DRGs. To
overcome the problem, we crossed GrpCre-KI mice with a ﬂoxstop channel rhodopsin-eYFP (ChR2-eYFP) line (Ai32)44 to
generate mice with ChR2-eYFP expression in Grp neurons
(GrpChR2) (Fig. 5a, b) so that Grp sensory neurons can be optoactivated to assess their role in itch and pain. As with GrptdTom,
ChR2-eYFP was detected in both CGRP+ and IB4-binding sensory neurons in GrpChR2 mice (Supplementary Fig. 5a), whereas
ChR2-eYFP was absent in GrpWT;Ai32 mice (Supplementary
Fig. 5b). eYFP was also detected in nerve ﬁbers of the nape skin
and cheek skin that expressed βIII-tubulin (Fig. 5c, Supplementary Fig. 5d), but no ChR2-eYFP was detected in GrpWT;Ai32
mice (Supplementary Fig. 5c). We also detected GrpChR2 ﬁbers in
the glabrous skin that appeared intertwined or co-expressed with
some CGRP+ ﬁbers in both the dermal and epidermal layers
(Supplementary Fig. 5e). Moreover, DiI injection was injected
into the nape or cheek skin to retrogradely label DRG neurons45
that conﬁrmed GrpChR2 DRG neurons innervate the nape skin
(Supplementary Fig. 5f), as well as GrpChR2 TG neurons that
innervated the cheek skin (Supplementary Fig. 5g).
To assess whether activation of Grp sensory neurons transmits
itch-speciﬁc information, we took advantage of Grp ﬁber innervation

in the skin and observed corresponding behaviors upon optogenetic
activation. GrpChR2 mice were stimulated with 473 nm blue light
with a ﬁber optic held just above the nape skin (15 mW power
from ﬁber tip) at 1, 5, 10, or 20 Hz with a 3-s On-Off cycle
for 5 min total (Fig. 5d). Notably, GrpChR2 mice exhibited
signiﬁcant scratching behaviors during blue light stimulation
trials at 10 and 20 Hz, whereas GrpWT mice showed almost no
scratching (Fig. 5e, f, Supplementary Fig. 6a, Supplementary
Movie 1, 2). For the 3 s stimulation trials that induced
scratching, the latency to scratch was ~1.7 s (Supplementary
Fig. 6b). At 20 Hz, the percentage of trials that induced
scratching in GrpChR2 mice was much greater compared to
GrpWT mice (43.2 vs 2.5%, p < 0.001) (Supplementary Fig. 6c).
Similarly, the total number of scratches induced during the
5 min test at 20 Hz was signiﬁcant compared to GrpWT mice
(24.3 vs 1.9 scratches, p < 0.001) (Fig. 5g). To determine whether
the blue light-induced scratching behaviors were indicative of
pain or itch, we treated GrpChR2 mice with systemic morphine
(5 mg kg−1 intraperitoneal) for analgesia since morphine-induced
scratching and analgesia are mediated by distinct pathways in
the spinal cord46. We found that morphine analgesia in GrpChR2
mice had no signiﬁcant effect on scratching induced by 20 Hz
blue-light stimulation (Fig. 5g) or on the percentage of trials
inducing scratching behavior (Supplementary Fig. 6c). This
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ﬁnding suggested that scratching is likely to be itch-related
rather than pain. To conﬁrm this, intrathecal injection (i.t.) of
bombesin-saporin (BB-sap, 200 ng) was performed to ablate
GRPR neurons in the spinal cord and block itch transmission47.
Indeed, GrpChR2 mice treated with BB-sap showed a signiﬁcant
reduction in scratching (24 vs 8 scratches, p < 0.001) (Fig. 5g) as
well as the percentage of trials inducing scratching behaviors at
20 Hz (43.2 vs 14.4%, p < 0.001) (Supplementary Fig. 6c). We
monitored spontaneous scratching behaviors for 30 min prior to
and 30 min following the 5 min-20 Hz stimulation test and found
a signiﬁcant increase in scratching following stimulation in
GrpChR2 mice compared to GrpWT (68 vs 14 scratches, p < 0.001),
which was not affected by morphine analgesia but was almost
completely blocked in BB-sap treated mice (68.4 vs 10.1, p <
0.001)(Supplementary Fig. 6d). Lastly, we crossed GrpCre-KI
mice with a Flox-stop hM3Dq DREADD (designer receptors
exclusively activated by designer drugs) line (R26-LSL-GqDREADD)48 to generate mice with hM3Dq expression in Grp
neurons (GrpGq), so that Grp neurons can be activated by
clozapine-N-oxide (CNO). To assess the role of Grp sensory
neurons in itch and pain, we employed the cheek model that can
differentiate itch behaviors as scratching with the hind limb and
pain behaviors as wiping with the forelimb49. Notably, we found
that injection of CNO into the cheek skin of GrpGq mice induced
robust scratching responses (36 scratches in 30 min) (Supplementary Fig. 6e). In contrast, GrpWT mice barely showed cheek
scratching responses to CNO injection (4 scratches in 30 min)
due to lack of DREADD (Supplementary Fig. 6e). Importantly,
both GrpGq and GrpWT mice showed minimal wiping behaviors
to CNO injections into the cheek (Supplementary Fig. 6e). These
data indicate that activation of Grp sensory neurons selectively
transmits itch sensation.
6

Conditional deletion of sensory Grp attenuates itch behavior.
Previous evidence from global Grp KO mice indicated that loss of
GRP attenuated non-histaminergic itch behavior, whereas histaminergic itch and pain transmission were normal16. However, it
remained unclear whether the source of GRP from sensory
neurons, spinal neurons or the brain were important for itch. To
determine the role of GRP in sensory neurons, we generated a
ﬂoxed Grp allele and crossed it with the sensory neuron speciﬁc
Cre-recombinase line, NaV1.8Cre 50, to conditionally delete Grp
expression in sensory neurons (Fig. 6a). Grp mRNA expression
was mostly absent in DRG of GrpF/F;NaV1.8Cre mice compared to
GrpF/F control littermates (Fig. 6b), but Grp mRNA expression in
the dorsal horn was not affected (Supplementary Fig. 7a). Consistent with ISH data, IHC of GRP showed that GRP+ neurons
were rarely seen in DRG of GrpF/F;NaV1.8Cre mice, demonstrating the deletion of GRP in DRGs (Fig. 6c). As predicted, GRP+
primary afferents in the dorsal spinal cord of GrpF/F;NaV1.8Cre
mice were also mostly absent (Fig. 6d, e). Western blot analysis
using the same GRP antibody detected a 15.6-kDa band that
corresponds to the size of GRP preproprotein in GrpF/F DRG and
the spinal cord (Fig. 6f, lane 1, red arrow), but only a faint band in
DRG of GrpF/F;NaV1.8Cre mice, with a normal non-speciﬁc band
of 30 kDa as an internal control (Fig. 6f, lane 2). Importantly, the
GRP band in the spinal cord of GrpF/F;NaV1.8Cre mice was also
signiﬁcantly reduced compared to the control (Fig. 6f, lane 2).
These results indicate that the vast majority of GRP protein in the
spinal cord is of primary afferent terminal origin, consistent with
our previous results19. Notably, GRP IHC in the SCN is comparable between GrpF/F and GrpF/F;NaV1.8Cre littermates, as we
previously described10, further demonstrating the speciﬁcity of
GRP deletion in sensory neurons (Supplementary Fig. 7b). Next,
we performed acute itch behavior tests and found signiﬁcant
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reductions of scratching behavior in GrpF/F;NaV1.8Cre mice
compared to GrpF/F control for the non-histaminergic pruritogens CQ (240 ± 24 vs 143 ± 16 scratches, p < 0.01) (Fig. 6g), the
PAR2 agonist SLIGRL-NH251 (222 ± 17 vs 109 ± 23 scratches, p <
0.01) (Fig. 6h), and the MrgprC11 agonist BAM8-2252 (46 ± 4 vs
29 ± 3 scratches, p < 0.01) (Fig. 6i). However, GrpF/F;NaV1.8Cre
mice and GrpF/F control showed similar scratching behavior for
histamine (53 ± 6 vs 51 ± 7 scratches, p = 0.79) (Fig. 6j) and βalanine (36 ± 27 vs 52 ± 29 scratches, p = 0.31) (Fig. 6k), the latter
of which is mediated by MrgprD53. Recently, Albisetti et al.24
reported that Grp neurons in the lumbar spinal cord is involved
in pruritogens-evoked biting behaviors to the calf. The biting
behavior in the calf model has been used as a readout for itch54,55.
To validate the model, we examined biting/licking time after calf
injections of pruritogens and found that GrpF/F;NaV1.8Cre mice
and GrpF/F control showed similar responses to CQ (98 ± 17 vs
107 ± 28 s, p = 0.78), SLIGRL-NH2 (114 ± 30 vs 88 ± 24 s, p =
0.52), and BAM8-22 (82 ± 9 vs 78 ± 10 s, p = 0.76) (Supplementary Fig. 7c–e). We noticed that mice showed robust responses to
saline upon calf injections (49 ± 8 s)(Supplementary Fig. 7f),
suggesting that the injection itself caused irritation to the animals.
To evaluate if the biting/licking behaviors reﬂect itch, we performed i.t. injection of morphine (0.3 nmol, 30 min) and observed
its effect on calf CQ injection. We found that morphine abolished
biting/licking responses to calf CQ injection compared to saline
(116 ± 16 vs 10 ± 3 s, p < 0.001) (Supplementary Fig. 7g). CQinduced itch is dependent on GRPR neurons, which can be

ablated by i.t. bombesin-saporin (BB-sap)47. We found that calf
CQ injection-evoked biting/licking behaviors were not affected in
BB-sap-treated mice (Supplementary Fig. 7h). These results
indicate that injection of a pruritogen into the calf skin more
likely evokes inﬂammatory pain rather than itch responses
in mice.
Spinal Grp neurons are dispensable for itch and pain. To test
the role of spinal Grp interneurons in transmitting itch and pain
behaviors while not affecting Grp expressing neurons in the DRG
and brain, we used an intersectional genetic approach56,57 to
ablate Grp neurons speciﬁcally in the dorsal spinal cord and
spinal trigeminal nucleus subcaudalis (SpVc). GrpCre-KI mice
were crossed with the Lbx1Flpo and Tauds-DTR lines to express the
diphtheria toxin receptor (DTR) exclusively in Grp spinal neurons and mice were injected with diphtheria toxin (DTX) to
speciﬁcally ablate Grp spinal neurons (Fig. 7a). We tested the
efﬁciency of DTR-mediated ablation in the spinal cord by Grp
ISH (Fig. 7b–e) as well as GrptdTom neurons (Fig. 7f–i). Compared to control littermates, DTX injection resulted in ablation of
~82% of Grp neurons and ~93% of GrptdTom dorsal horn neurons
in ablated mice (Fig. 7j). Importantly, we conﬁrmed that
GrptdTom neurons in the DRG and brain (cingulate cortex, hippocampus) were not ablated following DTX injection (Supplementary Fig. 8a). We analyzed spinal interneuron populations
expressing PKCγ, Pax2, and Grpr, and found similar numbers of
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neurons in control and ablated mice (Supplementary Fig. 8b, c).
Npr1 neurons were reduced slightly but did not reach statistical
signiﬁcance (77 ± 3 vs 68 ± 3 neurons, p = 0.07) (Supplementary
Fig. 8b, c). This was supported by single-cell RT-PCR results
showing 20–25% co-expression of Npr1 or Npr3 in GrptdTom
neurons (Supplementary Fig. 9) as well as no co-expression of
GrptdTom in PKCγ cell bodies (Supplementary Fig. 8b). The small
percentage of overlap between spinal Grp and Npr1 is consistent
with recent studies using single nucleus RNA sequencing
(snRNA-seq) of spinal cord neurons58. Moreover, RNAscope ISH
showed that ~40% of NMBR neurons express Grp, whereas about
25% of Grp neurons express TacR3, a receptor implicated in
pain59 (Supplementary Fig. 9). To determine the role of spinal
Grp neurons in itch and pain transmission, we tested acute itch
and pain behaviors pre- and post-DTX injection in control and
ablated mice. Scratching behaviors for CQ and histamine were
similar prior to and following DTX injection in control and
ablated mice with no signiﬁcant differences (Fig. 7k, l). Our
ﬁnding is in accordance with the observation that few Grp neurons seldom expressed c-Fos in response to CQ injection60.
Wiping behaviors for capsaicin cheek injection were also comparable between control and ablated mice both pre- and
8

post-DTX injection (Fig. 7m). Thermal response latencies for hot
plate and Hargreaves hind-paw assays were comparable in control and ablated mice both pre- and post-DTX injection, as well as
no changes in mechanical thresholds by von Frey ﬁlament assay
(Fig. 7n–p). Taken together, the ﬁnding that speciﬁc ablation of
spinal Grp neurons does not signiﬁcantly affect itch or pain
behavior responses suggests that spinal Grp neurons are dispensable for itch and pain transmission.
Discussion
Using newly generated ﬂoxed Grp mice, we demonstrate the role
of GRP in sensory neurons for CQ- but not histamine-evoked
itch behavior, in agreement with the phenotype of global Grp KO
mice5,16,47. Analysis of the GrpCre-KI mouse line reveals a widespread innervation of the skin by GRP ﬁbers whose activation by
optogenetics and chemogenetics evokes itch-related scratching
behavior. Importantly, intersectional genetic ablation approach
demonstrates that spinal Grp neurons are dispensable for itch
transmission.
Despite co-expression of CGRP in the cell bodies of some Grp
neurons, Grp epidermal ﬁbers mostly lack detectable levels of
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CGRP, indicating differences in expression/trafﬁcking of CGRP
between cell body and free nerve endings. Moreover, the morphological characteristics of Grp epidermal ﬁbers and their elaborate innervation patterns in the stratum granulosum are
consistent with a non-peptidergic proﬁle that was previously
described in Mrgprd ﬁbers30. That a small percentage of Grp
neurons gave rise to extensive branching in the skin is in sharp
contrast to a progressively restriction of CGRP expression in the
terminals, possibly reﬂecting the difference in terminal transportation of neuropeptides. The broad innervation of Grp ﬁbers
matches dense innervation of the superﬁcial dorsal horn by
central terminals of GRP primary afferents. The ﬁnding that more
than 60% of Mrgpra3 express GRP is in support of previous
studies indicating that Mrgpra3 afferents form synaptic contacts
with GRPR neurons and use GRP to transmit CQ as well as other
non-histaminergic itch39,43,47. In line with this, GRP and/or
Mrgpra3 were found to be up-regulated in DRGs of mice with
chronic itch7,19,21,61. Of note, not all Grp neurons were responsive to CQ, histamine, and capsaicin, as measured by calcium

imaging studies. These non-responding neurons may express
receptors for pruritogens which were not investigated in our
study. Given increasing numbers of receptors/TRP channels in
DRGs have been implicated in itch62–66, it is likely that modality
speciﬁcity is in part encoded through the differential activation
and release of myriad neuropeptides. Whether a broad innervation of the epidermis by a small subset of pruriceptors may reﬂect
a signature of modality-speciﬁc sensory neurons remains to
be determined.
Of several putative itch-related primary afferents, to date only
scratching behavior evoked by optogenetic and chemogenetic
activation of cutaneous GRP ﬁbers has been validated to be itchrelated. The reduced GRP IHC staining in the central terminals
after CQ injection provides a causal link between itch-related
scratching behavior and potential release of GRP into the spinal
cord. Notably, in spite of overlapping expression of SP and GRP
in DRGs19, no reduction of SP IHC was observed in response to
CQ, raising the possibility that GRP and SP are differentially
released onto the spinal cord, depending on the nature of stimuli.
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The fact that mice spend signiﬁcant amount of awake time
scratching themselves implies a constant spontaneous release of
GRP. This contrasts the difﬁculties of evoked SP release, which
likely induces pain-like behavior. Hence, distinct mechanisms
may control release of GRP vs. SP from the large dense core
vesicles in the central terminals, respectively. To the best of our
knowledge, our study represents the ﬁrst comprehensive validation of itch-related scratching behavior evoked by cutaneous
activation of a subset of primary afferents using a combination of
approaches, including both nape and cheek models. Given the
complexity of scratching behaviors in mice, our strategy as
described here can be used to differentiate between itch- and
pain-related scratching behavior and thus to identify itch- or
pain-related primary afferents in sensory neurons. The present
study also cautions the use of alternative behavioral outputs (e.g.
licking/biting) as a proxy for itch behavior.
Prior studies with global ablation of Grp-Cre neurons found
impaired itch and enhanced pain behaviors25. The deﬁcits are
more likely caused by ablation of Grp-Cre neurons in the brain
rather than the spinal cord since Grp-Cre neurons are found
in several pain-modulating areas in the brain, including mPFC
or ACC. Moreover, while spinal Grp neurons do not express
PKCγ 67, Sun et al. ablated ~50% of PKCγ neurons, indicating
extensive ectopic ablation even in the dorsal horn neurons25.
By contrast, our intersectional strategy did not impact PKCγ
expression. Based on the premise that GRP is not expressed in
DRGs, a recent study suggested that repeated stimulation of
spinal Grp-Cre neurons activated GRPR neurons through GRP/
glutamate released from spinal Grp neurons24. However, the
release of GRP can be alternatively attributable to concurrent
stimulation of Mrgpra3/GRP afferents which innervate spinal
Grp neurons23. Furthermore, given Mrgpra3 ﬁbers also express
NMB68, which can activate Grp/NMBR neurons, conceivably,
stimulation of Grp/NMBR neurons per se, either directly, or
indirectly, could activate downstream GRPR neurons via glutamatergic transmission as we previously described16. It should be
noted that these possibilities are not mutually exclusive. Importantly, the observation of normal itch and pain behavior of mice
with spinal ablation of Grp neurons should not be mistaken for
their unimportance. On the contrary, Grp neurons could be an
integral part of distinct “gates” or “labeled lines” for itch and pain
transmission, and the net effect of deletion of a small percentage
of which conceivably could be negligible at behavioral level.
Our ﬁnding that Grp neurons are molecularly and functionally
heterogenous raises an important question of what may constitute
the appropriate criteria for categorizing the dorsal horn interneurons concerning the coding of sensory modality. With the
aid of powerful chemogenetic/optogenetic/ablation approaches,
recent studies have capitalized on a dozen of Cre lines, mostly
based on neuropeptides, transcription factors, or generic
enzymes/channels/transporters, in identiﬁcation of a number of
“gates” for itch and pain. Such circuit-based approaches, albeit
necessary, might be insufﬁcient, or in some cases could even
complicate our ability to identify the true labeled lines in the
spinal cord if the Cre expression is either widespread in the dorsal
horn or cross several discrete microcircuits. Given dozens of
neuropeptides identiﬁed in sensory neurons69, predominant role
of GPCRs in pain and itch70, and the exquisite modular organization of laminae I–II circuitry that permits dedicated transmission of sensory information71, an understanding of how
information encoded by neuropeptides in DRGs is transmitted
and processed by their respective GPCRs in laminae I–II could
be essential for decoding sensory processing. In this regard, a
GPCR-based Cre line could be advantageous since it affords
functional, electrophysiological, and pharmacological interrogation of microcircuits in the context of input–output ﬂow. After all,
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our goal is to understand how discrete somatosensory information
is transmitted from sensory neurons to the spinal cord. While
expression of GPCRs may overlap, by examining ligand-mediated
activation under both basal and various physiological conditions,
one may still be able to infer the coding logic by which distinct
modality-speciﬁc microcircuits are differentially modulated.
In conclusion, using conditional deletion of GRP in sensory
neurons, we have established the role of GRP as an itch-speciﬁc
neuropeptide in transmitting nonhistaminergic itch. Using
intersectional genetic ablation of spinal GrpCre-KI neurons, we
have shown that spinal Grp neurons are dispensable for itch and
pain transmission. By using the gold-standard behavioral assay
for itch, our data strongly suggest that GRP primary afferents
constitute a labeled line for itch. The newly generated mouse
lines, along with ﬂoxed Grpr10, GrpriCre 72 we previously generated, offer unprecedented access to the GRP-GRPR system for
unraveling the coding logic of itch as well as the phenotypic
change consequent to the development of chronic itch in a celltype- and region-speciﬁc manner.
Methods
Mice. Mice between 7 and 12 weeks old were used for experiments. Ai14 (Stock no.
007908), Ai32 (Stock no. 024109), R26-LSL-Gq-DREADD (Stock no. 026220), and
C57Bl/6J mice were purchased from Jackson Laboratory, the Nav1.8Cre line50 was
kindly provided by the J. Wood lab, and the Lbx1Flpo and Tauds-DTR lines56,57 were
kindly provided by the Q. Ma and M. Goulding labs. Mice were housed in clear
plastic cages with no more than 5 mice per cage in a controlled environment at a
constant temperature of ~23 °C and humidity of 50 ± 10% with food and water
available ad libitum. The animal room was on a 12/12-h light/dark cycle with lights
on at 7 am. All experiments were performed in accordance with the guidelines of
the National Institutes of Health and the International Association for the Study of
Pain and were approved by the Animal Studies Committee at Washington University School of Medicine.
Generation of GrpCre-KI mice. A ~6-kb genomic DNA fragment containing Grp
exon 1 was PCR ampliﬁed from a BAC clone (RP-23, id. 463E10, ThermoFisher
Scientiﬁc) with a high-ﬁdelity DNA polymerase (CloneAmp HiFi PCR mix,
Clontech) and subcloned into pBluescript KS. An eGFP-Cre and frt-ﬂanked PGKNeomycin cassette for positive selection were integrated into exon 1 ATG start site
using an In-Fusion® HD Cloning Kit (Clontech). A diphtheria toxin α (DTA)
cassette was inserted downstream of the 3′ homology arm of the construct as a
negative selection marker. The construct was linearized with AscI and electrorporated into AB1 embryonic stem cells. Following negative selection with G418
(200 ng μL−1), positive clones were identiﬁed by 5′ and 3′ PCR screening. Positive
clones were injected into C57Bl/6J blastocysts to generate chimeric mice. After
breeding, germ-line transmission was conﬁrmed by genotype PCR, mice were bred
to a FRT-deleter line (Stock. No. 007844, Jackson Laboratory) to remove the
Neomycin cassette and were subsequently backcrossed into the C57Bl/6J
background.
Generation of Grp ﬂoxed mice. A ~10-kb genomic DNA fragment containing Grp
exon 1 was ampliﬁed and loxP sites were integrated into the fragment to ﬂox exon
1. A frt-ﬂanked PGK-Neomycin cassette for positive selection was integrated into
intron 1. A diphtheria toxin α (DTA) cassette was inserted downstream of the 3′
homology arm of the construct as a negative selection marker. The construct was
linearized with KpnI and electroporated into AB1 embryonic stem cells. Following
negative selection with G418 (200 ng μL−1), positive clones were identiﬁed by 5′
and 3′ PCR screening. Positive clones were injected into C57Bl/6J blastocysts to
generate chimeric mice. After breeding, germ-line transmission was conﬁrmed by
genotype PCR, mice were bred to an FRT-deleter line (Stock. No. 007844, Jackson
Laboratory) to remove the Neomycin cassette and were subsequently bred with
Nav1.8Cre mice or backcrossed into the C57Bl/6J background.
In situ hybridization. Conventional ISH was performed using a digoxigeninlabeled cRNA (Roche) antisense probe for Grp (bases 149–707 of Grp mRNA,
NCBI accession NM_175012.4)19. In all, 7–12-week-old mice were anesthetized
(ketamine, 100 mg kg−1 and Xylazine, 15 mg kg−1) and perfused intracardially
with DEPC-treated PBS pH 7.4 followed by 4% paraformaldehyde (PFA) in
DEPC-treated PBS. Tissues were dissected, post-ﬁxed for 2–4 h, and cryoprotected in 20% sucrose in PBS overnight at 4 °C. Cervical, thoracic and lumbar
DRGs were sectioned in OCT at 20 μm thickness at 20 °C using a cryostat
microtome (Leica Instruments) and thaw-mounted onto Super Frost Plus
slides (Fisher). Slides were incubated with Proteinase K (50 μg mL−1) buffer for
10 min, incubated in prehybridization solution for 3 h at 65 °C and then incubated with Grp probe (2 μg mL−1) in hybridization solution overnight at 65 °C.

NATURE COMMUNICATIONS | (2020)11:1397 | https://doi.org/10.1038/s41467-020-15230-y | www.nature.com/naturecommunications

NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-15230-y

ARTICLE

After SSC stringency washes and RNase A (0.1 μg mL−1 for 30 min) incubation,
sections were incubated in 0.01 M PBS with 20% sheep serum and 0.1% Tween
blocking solution for 3 h and then incubated with anti-digoxigenin antibody
conjugated to alkaline phosphatase (0.5 μg mL−1, Roche) in blocking solution
overnight at 4 °C. After washing in PBS with 0.1% Tween, sections were incubated in NBT/BCIP substrate solution at room temperature for 12–16 h for
colorimetric detection. Reactions were stopped by washing in 0.5% paraformaldehyde in PBS. Bright ﬁeld images were taken using a Nikon Eclipse Ti-U
microscope with a Nikon DS-Fi2 Camera.
RNAScope™ Double ISH (Advanced Cell Diagnostics, Inc.) was performed
using the RNAScope™ Multiplex Fluorescent Reagent Kit v2 User Manual for Fixed
Frozen Tissue27. Tissues were dissected, post-ﬁxed for 2–4 h, and cryoprotected in
20% sucrose in PBS overnight at 4 °C. Cervical, thoracic and lumbar DRGs or
cervical spinal cord regions were sectioned in OCT at 20 μm thickness at 20 °C
using a cryostat microtome (Leica Instruments) and thaw-mounted onto Super
Frost Plus slides (Fisher). Brieﬂy, slides were incubated with hydrogen peroxide for
10 min, washed, mildly boiled in target retrieval reagents for 15 min, washed, dried,
and hydrophobic barriers were added around the sections. Protease III Plus
Reagent was applied for 15 min, washed and sections were incubated with target
probes for Grp (Mm-Grp-C1, GenBank: NM_175012.4, target region bases 22–825,
Cat No. 317861), Cre (Cre-O1-C3, GenBank: NC_005856.1, target region bases
2–972, Cat No. 474001-C3), Grpr (Mm-Grpr-C1, GenBank: NM_008177.2, target
region bases 463–1596, Cat No. 317871) or Npr1 (Mm-Npr1-C1, GenBank:
NM_008727.5, target region bases 941–1882, Cat No. 484531) probes for 2 h. All
target probes consisted of 20 ZZ oligonucleotides and were obtained from
Advanced Cell Diagnostics. Following probe hybridization, sections underwent a
series of probe signal ampliﬁcation steps followed by incubation of ﬂuorescently
labeled probes designed to target the speciﬁed channel associated with each probe.
Slides were counterstained with DAPI, and coverslips were mounted with
FluoromountG (Southern Biotech). Images were taken using a Nikon C2 + confocal
microscope system (Nikon Instruments, Inc.) and analysis of images was performed
using ImageJ software from NIH Image (version 1.34e)73. Positive signals were
identiﬁed as punctate dots and clusters present around the nucleus and/or
cytoplasm. For Grp/Cre mRNA co-expression, dot clusters of C1 and C3 channels
associated within a DRG cell body were counted as double positive, whereas
neurons with only C1 or C3 dot clusters were counted as single positive.

along the dorsal midline, the L4 and L5 DRG were exposed by removal of the
lateral processes of the vertebrae. The epineurium lying over the DRG was opened,
and the glass needle inserted into the ganglion, to a depth of 300 µm from the
surface of the exposed ganglion. After a 3-min delay to allow sealing of the
tissue around the glass capillary tip, 500 nl virus solution was injected at a rate
of 30 nl min−1. After a further delay of 2 min, the needle was removed. The L4
ganglion was injected ﬁrst followed by L5. The muscles overlying the spinal cord
were loosely sutured together with a 5–0 suture and the wound closed. Animals
were then placed in clean cage on paper towel with heated pad for recovery.

Immunohistochemistry. Mice were anesthetized (ketamine, 100 mg kg−1 and
Xylazine, 15 mg kg−1) and perfused intracardially with PBS pH 7.4 followed by 4%
paraformaldehyde (PFA) in PBS19. Tissues were dissected, post-ﬁxed for 2–4 h, and
cryoprotected in 20% sucrose in PBS overnight at 4 °C. For glabrous and mystacial
skin, tissues from 3-week-old mice were harvested immediately following anesthesia overdose, ﬁxed in 2% PFA-PBS with 30% (v/v) Picric acid overnight at 4 °C
and cryoprotected in 20% sucrose in PBS. Tissues were sectioned in OCT at 20 μm
thickness for DRG and spinal cord and 30 μm for all other tissues including tongue,
cornea, bladder, muscle, intestine, esophagus, heart, testis, liver, lung, kidney, and
skin. Free-ﬂoating frozen sections were blocked in a 0.01 M PBS solution containing 2% donkey serum and 0.3% Triton X-100 followed by incubation with
primary antibodies overnight at 4 °C, washed three times with PBS, secondary
antibodies for 2 h at room temperature and washed again three times. Sections
were mounted on slides and ~100 μL FluoromountG (Southern Biotech) was
placed on the slide with a coverslip. The following primary antibodies were used:
rabbit anti-GFP (1:1000, Molecular Probes, A11122), chicken anti-GFP (1:500,
Aves Labs, GFP-1020), rabbit anti-GRP (1:500, Immunostar, 20073), guinea pig
anti-SP (1:1000, Abcam, ab10353), rabbit anti-CGRP (1:3000, MilliporeSigma,
AB15360), guinea-pig anti-TRPV1 (1:800, Neuromics, GP14100), chicken anti-NFH (1:2000, EnCor Biotechnology, CPCA-NF-H), rabbit anti-βIII-Tubulin (1:2000,
Biolegend, 802001), rabbit anti-PKCγ (1:1000, Santa Cruz Biotechnology, SC-211),
rabbit anti-Pax2 (1:300, ThermoFisher Scientiﬁc, 71–6000) IB4-binding was performed using an IB4-AlexaFluor 488 conjugate (2 μg mL−1, ThermoFisher Scientiﬁc, I32450) and DAPI (2 μg mL−1, Sigma, D9542) was used as a nuclear stain of
cells. The following secondary antibodies were used: Alexa-Fluor 488 conjugated
donkey anti-rabbit (1:1000, Jackson Immuno-Research, 711–545–152), Alexa-Fluor
488 conjugated donkey anti-chicken (1:1000, Jackson ImmunoResearch,
703–545–155), Alexa-Fluor 488 conjugated donkey anti-guinea pig (1:1000, Jackson ImmunoResearch, 706–545–148). Cy3-conjugated donkey anti-rabbit (1:1000,
Jackson ImmunoResearch, 711–165–152) and Cy5-conjugated donkey anti-chicken
1:1000, Jackson ImmunoResearch, 703–175–155). Fluorescent Images were taken
using a Nikon C2+ confocal microscope system (Nikon Instruments, Inc.) and
analysis of images for neuron counting was performed using ImageJ software from
NIH Image (version 1.34e).

DRG culture and Ca2+ imaging. DRGs from GrptdTom mice were dissected in
neurobasal media (Invitrogen) and incubated with papain (30 μL in 2 mL media;
Worthington) for 20 min at 37 °C. After washing with PBS (pH 7.4), cells were
incubated with collagenase (3 mg/2 mL media; Worthington) for 20 min at 37 °C.
After washing with PBS, cells were dissociated with a ﬂame-polished glass pipette
in neurobasal media. Dissociated cells were collected through a cell strainer (BD
Biosciences) to remove tissue debris. Dissociated DRG cells were resuspended with
DRG culture media (2% fetal bovine serum, 2% horse serum, 2% B-27 supplement,
and 1X glutamine in neurobasal media; Invitrogen) and plated onto polyornithine–coated 12-mm-diameter round glass coverslips in a 24-well plate. After
16–24 h, cell culture media were replaced with Ca2+ imaging buffer (140 mM
NaCl, 4 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 5 mM glucose, 10 mM Hepes,
adjusted to pH 7.4 with NaOH). Fura-2 acetoxymethyl ester (fura-2 AM) (Invitrogen) was diluted to 2 mM stock in DMSO/20% pluronic acid. The coverslips
were mounted on a Warner Instruments recording chamber (RC 26 G) perfused
with Ca2+ imaging buffer at a rate of ~2 mL/min. An inverted microscope (Nikon
Eclipse Ti 10X objective) with Roper CoolSNAP HQ2 digital camera was used for
fura-2 Ca2+ imaging after 340/380-nm laser excitations (sampling interval, 2 s;
exposure time adjusted for each experiment to ~40 ms for 340 nm and to ~30 ms
for 380 nm). CQ (1 mM, Sigma), histamine (50 mM, Sigma), capsaicin (10 or 100 nM,
Sigma), or KCl (30 mM, Sigma) was applied to GrptdTom DRG cultures to examine
Ca2+ responses. Responsive neurons were identiﬁed as ROIs and F340/F380 ratios
were measured using NIS-Elements (version 3.1, Nikon) 41. Prism 7 (version 7.0c,
GraphPad) was used to analyze Ca2+ imaging data.

Virus injection into DRG. AAV5-EF1α-DIO-eYFP virus (2.4 × 1013 vg mL−1) was
purchased from the Hope Center Viral Vectors Core at Washington University
School of Medicine. The injection was performed with a borosilicate glass capillary
pulled to a ﬁne point (50 µm) 74, attached to a Hamilton syringe mounted in a QSI
automatic injector (Stoelting). The injector was then attached to a stereotaxic
apparatus (Stoelting). The y arm of the stereotaxic apparatus was adjusted to a 45°
angle. Animals were anesthetized using ketamine (100 mg kg−1, i.p.) and xylazine
(15 mg kg−1, i.p.) and placed in the stereotaxic apparatus. Following an incision

Real-time RT-PCR. DRG and spinal cords were dissected out on ice and stored in
RNA stabilizer (RNAlater, QIAGEN). Total RNA was isolated and genomic DNA
was removed in accordance with manufacturer’s instructions (RNeasy plus mini
kit; QIAGEN). Single-stranded cDNA was synthesized by using High Capacity
cDNA Reverse Transcription Kit (Life Technologies). Gene expression of Grp was
determined by real-time PCR (StepOnePlus; Applied Biosystems)46. Speciﬁc primers were designed with the NCBI Primer-BLAST. The primers used are:
Grp: 5′-TGGGCTGTGGGACACTTAAT-3′ (exon1); 5′-GCTTCTAGGAGGT
CCAGCAAA-3′; Actb: 5′-TGTTACCAACTGGGACGACA-3′; 5′-GGGGTGTTG
AAGGTCTCAAA-3′.
Real-time PCR was carried out with FastStart Universal SYBR Green Master
(Roche Applied Science). All samples were assayed in duplicates. Thermal cycling
was initiated with denaturation at 95 °C for 10 min. After this initial step, 40 cycles
of PCR (heating at 95 °C for 10 s and 60 °C for 30 s) were performed. Data were
analyzed using Comparative CT Method (StepOne Software v2.2.2.) and the
expression of Grp was normalized to the expression of Actb.
Retrograde labeling of DRG/TG neurons from skin. To retrogradely label DRG
or TG neurons innervating the hairy nape or cheek skin, the ﬂuorescent tracer 1,1′Dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate (DiI) (Sigma,
42364) was injected intradermally using a 30-G hypodermic needle. A total of
4–20 μL injections of 5% DiI was made within the nape region on the rostral back
skin or 2–20 μL injections into the cheek skin in GrpChR2 mice. After 10 days to
allow for labeling, mice were anesthetized, perfused and DRG and TG were dissected and processed for IHC.

Optical skin stimulation behavior. GrpChR2 mice and wild-type littermates
(GrpWT) were used for optical skin stimulation experiments. The nape skin was
shaved 3 days prior to stimulation in all mice tested. One day prior to the
experiments, each mouse was placed in a plastic arena (10 × 11 × 15 cm) for 30 min
to acclimate. Mice were videotaped using SONY HDR-CX190 digital video camcorders from a side angle. Mice were recorded for 30 min prior to stimulation for
spontaneous scratches. For blue light skin stimulation, a ﬁber optic cable that was
attached to a ﬁber-coupled 473 nm blue laser (BL473T8-150FC, Shanghai Laser
and Optics Co.) with an ADR-800A adjustable power supply. Laser power output
from the ﬁber optic cable was measured using a photometer (Thor Labs) and set to
15 mW from the ﬁber tip. An Arduino UNO Rev 3 circuit board (Arduino) was
programmed and attached to the laser via a BNC input to control the frequency
and timing of the stimulation (1, 5, 10, or 20 Hz with 10 ms on-pulse and 3 s On –
3 s Off cycle for 5 min). During stimulation, the mouse was traced manually by a
ﬁber optic cable with ferrule tip that was placed 1–2 cm above the nape skin.
Following stimulation, the mice were recorded for 30 min. for spontaneous scratches. Morphine (5 mg kg−1, i.p.) was injected 10 min prior to pre-stimulation
spontaneous scratching observations. Bombesin-saporin (200 ng/5 μL, i.t.,
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Advanced Targeting Systems, Cat No. IT-40) was injected 2 weeks prior to optical
stimulation. Videos were played back on a computer for assessments by observers
blinded to the animal groups and genotypes. A scratch was deﬁned as a lifting of
the hind limb towards the nape or head to scratch and then a replacing of the limb
back to the ﬂoor, regardless of how many scratching strokes take place between
lifting and lowering of the hind limb.
Western blot. DRG and lumbar spinal cord of 9-week-old WT and Grp cKO mice
were dissected on ice and quickly frozen in −80 °C. Soluble cell plasma proteins
were extracted as described75. Samples were removed into a microtube containing
ice-cold sample buffer (20 mM Tris-HCl [pH 7.4], 1 mM dithiothreitol, 10 mM
NaF, 2 mM Na3VO4, 1 mM EDTA, 1 mM EGTA, 5 mM microcystin-LR, and
0.5 mM phenylmethylsulfonyl ﬂuoride), and homogenized by sonication. Homogenates were centrifuged at 12,000 × g for 30 min at 4 °C. The supernatant was used
for analysis. Protein concentration was determined using BCA assay (Thermo
Scientiﬁc). For each sample, 10 µg of total protein were separated on SDS NuPAGE
Bis-Tris 4–12% gels (Life Technology) in MES running buffer (Life Technology)
and transferred to polyvinylidene ﬂuoride membrane (Life Technology). The blots
were blocked in blocking buffer (5% nonfat dry milk in PBS and 0.1% Tween 20)
for 1 h at room temperature and incubated with rabbit anti GRP (ImmunoStar,
1:5,000), for 16 h at 4 °C. This was followed by 1 h incubation in goat horseradish
peroxidase-linked secondary antibodies (Santa Cruz) at 1:2500. Immunoblots were
developed with the enhanced chemiluminescence reagents (Amersham).
Diphtheria toxin receptor-mediated ablation of Grp spinal neurons. To ablate
DTR-expressing Grp spinal neurons for behavioral and histochemical studies,
GrpWT; Lbx1Flpo; Tauds-DTR control or GrpCre-KI; Lbx1Flpo; Tauds-DTR littermates
were intraperitoneally injected with diphtheria toxin (DTX, 40 μg kg−1; Sigma Cat.
No. D0564) dissolved in saline at day 1 and then again at day 4. Behavioral, ISH
and IHC experiments were performed 2 weeks after DTX injection.
Single-cell qRT-PCR. Single-cell qRT-PCR was carried out using Ambion® Single
Cell-to-CT™ Kit (Life technologies) in accordance with manufactures instructions.
Brieﬂy, single tdTomato neuron in laminae I-II of spinal cord slices from GrptdTom
mice was identiﬁed by red ﬂuorescence under microscope. Negative pressure was
applied to the pipette to isolate cytosol of the cell, which was extruded into 10 μl
cell lysis/Dnase I solution for RNA extraction and genomic DNA digestion. After
reverse transcription (25 °C,10 min/42 °C, 60 min/85 °C, 5 min) target cDNA was
pre-ampliﬁed for 14 cycles (95 °C, 15 s/60 °C, 4 min) in the presence of 0.2x pooled
TaqMan assays (ThermoFisher Scientiﬁc). Diluted pre-ampliﬁcation products (1:20
in 1x TE buffer) was used for ﬁnal qPCR reaction (4 μl, 40 cycles of 95 °C 5 s/60 °C
30 sec; StepOnePlus, Applied Biosystems) to examine target gene expression.
TaqMan assays used are: Actb, Mm01205647_g1; Grp Mm00612977_m1, Grpr,
Mm01157247_m1; Nmbr, Mm00435147_m1; Npr1, Mm01220076_g1; Vglut2,
Mm00499876_m1; Pdyn, Mm00457573_m1; Sst, Mm00436671_m1; Npy,
Mm01410146_m1; Tacr1, Mm00436892_m1. Data were analyzed using StepOne
Software (v2.2.2.) with automatic baseline and threshold was set to 0.2.
Acute itch behavior. Behavioral experiments were performed during the day
(0800–1500 h)16. For injections, mice had their nape shaved a day before the
experiments. One day prior to the experiments, each mouse was placed in a plastic
arena (10 × 11 × 15 cm) for 30 min to acclimate. On the test day, mice were given at
least 10 min to get accustomed to recording conditions prior to injections and
recordings. CQ (200 μg, Sigma), SLIGRL-NH2 (100 μg, Genscript), BAM8-22
(100 μg, Genscript), histamine (200 μg, Sigma), or β-alanine (100 μg, Sigma) dissolved in a volume of 50 μL saline was injected intradermally using a syringe
attached to a SS30M3009 – 3/10 cc, 30 G × 3/8″ needle (Terumo). Immediately
after injections, mice were put into rectangular, transparent observation boxes and
videotaped from a side angle. The videos were played back on a computer and
quantiﬁed by an observer who was blinded to the treatment or genotype. A scratch
was deﬁned as a lifting of the hind limb towards the nape or head to scratch and
then a replacing of the limb back to the ﬂoor, regardless of how many scratching
strokes take place between lifting and lowering of the hind limb. Only scratches to
the injection site were counted for 30 min.
Acute pain behavior. Capsaicin cheek behavior: 1 day prior to injection, the cheek
skin was shaved. On the test day, mice were given at least 30 min to get accustomed
to recording conditions prior to injections and recordings. Capsaicin (20 μg) dissolved in a volume of 20 μL saline with 2% ethanol and 2% Tween was injected
intradermally to the cheek using a syringe with 30 G × 3/8″ needle. Immediately
after injections, mice were put into rectangular, transparent observation boxes and
videotaped from a side angle. The videos were played back on a computer and
quantiﬁed by an observer who was blinded to the treatment or genotype. A wipe
was deﬁned as a singular motion of one forelimb beginning at the caudal extent of
the cheek and proceeding in a rostral direction. Only wipes to the injection site
were counted for 30 min.
Thermal sensitivity: thermal sensitivity was determined using hotplate (50, 52,
or 56 °C), and Hargreaves assay. For the hotplate test, the latency for the mouse to
lick its hindpaw or jump was recorded. For the Hargreaves test, thermal sensitivity
12

was measured using a Hargreaves-type apparatus (IITC Inc.). The latency for the
mouse to withdraw from the heat source was recorded.
Mechanical sensitivity: mechanical thresholds were assessed using a set of
calibrated von Frey ﬁlaments (Stoelting). Each ﬁlament was applied 5 consecutive
times and the smallest ﬁlament that evoked reﬂexive ﬂinches of the paw on 3 of the
5 trials was taken as paw withdrawal threshold.
Calf injections: for calf injections, mice had their calf shaved a day before the
experiments. One day prior to the experiments, each mouse was placed in a
plastic arena (10 × 11 × 15 cm) for 30 min to acclimate. On the test day, mice were
given at least 10 min to get accustomed to recording conditions prior to injections
and recordings. CQ (100 µg), SLIGRL-NH2 (100 µg), or BAM8-22 (100 µg)
dissolved in a volume of 10 µL saline was injected intradermally using a syringe
attached to a SS30M3009 – 3/10 cc, 30 G × 3/8″ needle (Terumo). Immediately
after injections, mice were put back to the plastic arena and videotaped from a
side angle. For morphine analgesia experiments, saline (10 µL) or morphine
(0.3 nmol in 10 µL saline) was administrated via intrathecal injection. Mice then
received calf injection of CQ (100 µg) 30 min later. The videos were played back
on a computer and quantiﬁed by an observer who was blinded to the treatment or
genotype. The time the animal spent on biting/licking toward injection site were
counted for 30 min.
Statistics. Statistical methods are indicated when used. Values are reported as the
mean ± standard error of the mean (SEM). Statistical analyses were performed
using Prism 7 (v7.0d, GraphPad, San Diego, CA). For comparison of 1, 5, 10, and
20 Hz stimulation-induced scratching in Grpwt and GrpChR2 mice, a one-way
ANOVA with Tukey post hoc analysis was performed. For comparison between
Grpwt, GrpChR2, GrpChR2-morphine, and GrpChR2-BB-Sap behavior analysis
during light stimulation, a one-way ANOVA with Tukey post hoc analysis was
performed. For comparison between of Grpwt, GrpChR2, GrpChR2-morphine, and
GrpChR2-BB-Sap behavior analysis prior to and following light stimulation, a twoway repeated measures ANOVA with Tukey post hoc analysis was performed.
For comparison between GrpF/F and GrpF/F; Nav1.8Cre mice acute itch behavior,
unpaired t test was performed. For comparison between Grp control and Grp
spinal ablated dorsal horn neuron numbers of various IHC and ISH markers,
unpaired t test was performed. For comparison between Grp control and Grp
spinal ablated mice pre- and post-DTX injection, two-way repeated measures
ANOVA with Tukey post hoc analysis was performed. Normality and equal
variance tests were performed for all statistical analyses. P < 0.05 was considered
statistically signiﬁcant.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.

Data availability
The authors declare that all data supporting the ﬁndings of this study are available within
the paper and its supplementary information ﬁles. The source data underlying Figs. 1h, i,
4d, 5g, 6f–k, h, and 7j–p and Supplementary Figs. 1e, 6a–f, 7c–h, and 8c are provided as a
Source Data ﬁle.
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